The Valley Desk

NCT03058289 · Interventional trial

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Overall registry status Completed

Phase 1 · Phase 2

Conditions Bile Duct Cancer, Breast Cancer, Chordoma of Sacrum, Colon Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Lymphoma, Pancreatic Cancer, Sarcoma, Squamous Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov